Analysis of Frailty Syndrome in Patients

Analysis of the Pathophysiology of Frailty Syndrome and Clinical Development of Frailty Within the Framework of the Innovation Fund Project PRÄP-GO (ANA-PRÄP-GO)

Observational Charite University, Berlin, Germany · NCT04880824

This study is trying to better understand frailty syndrome by looking at different aspects of it in patients who are frail, along with a control group of non-frail patients and their family members.

Quick facts

Study typeObservational
Enrollment1640 (estimated)
Ages70 Years and up
SexAll
SponsorCharite University, Berlin, Germany Academic / other
Locations27 sites (Schwante, Brandenburg and 26 other locations)
Trial IDNCT04880824 on ClinicalTrials.gov

What this trial studies

This study aims to characterize and phenotype frailty syndrome through a comprehensive observational approach. Participants will include patients with frailty from the PRÄP-GO intervention study, a non-frail surgical control group, and a non-surgical comparison group. The study will evaluate various clinical, psychosocial, and pathophysiological aspects related to frailty. Additionally, relatives of patients may also participate, contributing to a broader understanding of the condition.

Who should consider this trial

Good fit: Ideal candidates include patients aged 70 and older scheduled for elective surgery who do not exhibit frailty syndrome.

Not a fit: Patients with severe cardiac or pulmonary diseases, moribund conditions, or significant neuropsychiatric impairments may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved management and treatment strategies for frailty syndrome, enhancing patient outcomes.

How similar studies have performed: While there have been studies on frailty, this specific approach of detailed characterization within a multimodal intervention framework is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
PG cohort:

Inclusion criteria

* Consent given and inclusion in PRÄP-GO
* Patient capable of giving consent or existing legal guardian in the case of patients not capable of giving consent

Exclusion criteria

- None

NFC cohort:

Inclusion criteria

* Patient capable of giving consent or existing legal guardian in the case of patients not capable of giving consent
* Age ≥ 70 years
* Elective surgery planned
* Expected anesthesia duration\> 60 min
* No frailty syndrome (0 positive out of 5 standardized parameters) according to the physical frailty phenotype (Fried et al., 2001)

Exclusion criteria

* Severe cardiac or pulmonary disease (NYHA IV, Gold IV)
* Intracranial interventions
* Moribund patients (palliative situation)
* Patients with a neuropsychiatric clinical picture or severe hearing and / or visual acuity impairment (not compensated by visual or hearing aids), which limit the performance of the neurocognitive tests
* Insufficient language skills
* Participation in another interventional rehabilitation study or a study according to the German Drug Law or the medical Device Law that has not been approved by the study leader (Exception: parallel participation in adjuvant therapy study).

NO cohort:

Inclusion criteria

- Age ≥ 70 years

* No elective surgery planned
* No surgery within 6 months prior to study enrollment

Exclusion criteria - See NFC cohort

GB cohort:

Inclusion criterion

- Doctor, nurse or therapist from the cooperation partners of PRAEP-GO who were involved in the project

Exclusion criterion

- Language barrier

Relatives:

Inclusion criteria

* Member of a patient in the PRÄP-GO cohort
* Age ≥ 18 years

Exclusion criterion

- Language barrier

Where this trial is running

Schwante, Brandenburg and 26 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Frailty Syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.